Technologies On The Shelf

Novel 64cu(Ii) Radiotracer For Diagnostic Of Hypoxia

By Merav Burstein | Dec 17, 2020

The Problem The development of a biomarker for hypoxic tissues is essential both for diagnostic formulation and treatment planning for…

Improved Tumor Margins Detection Using Gold Nano-rods

By Merav Burstein | Dec 17, 2020

The Problem Most optical-physiological diagnoses are based on the insertion of light, with known parameters, to a tested tissue, followed…

An Interactive Gaze Contingent System for the Diagnosis and Treatment of Social Communication and Attention Deficits in Infants and Children

By Merav Burstein | Dec 17, 2020

The Problem Over the last two decades a dramatic increase in the prevalence of socio-communicative disorders and attention disorders was…

Metabolic Imaging Of Cancer Using CT

By Merav Burstein | Dec 17, 2020

The Problem Current conventional structural diagnostic modalities do not detect evident of cancer lesions at early stages as they are…

Glucose Conjugated Gold Nano-particles for Cancer Detection

By Merav Burstein | Dec 17, 2020

The Problem Cancer detection is currently based on two insufficient imaging techniques: structural and functional. While structural techniques identify anatomic…

« Previous
1
…
6
7
8

Licensing

BIRAD grants exclusive and non-exclusive licenses for the commercialization of BIU-based research findings, both to established companies and to new startup ventures established around University technology.

The licenses are granted for specific patents and/or know-how and are limited to a specific field and/or specific products. Licenses include diligence milestones for the development and sale of products covered by the license – to avoid technology "shelving" – and typically include a combination of the following forms of consideration: royalties, milestone payments, upfront fees, equity and/or annual license fees.